Illumina DNA Sequencing Patent Survives AIA Review
Intelligent Bio-Systems Inc. failed to prove that Illumina Cambridge Ltd.'s DNA sequencing patent is invalid as obvious, the U.S. Patent and Trademark Office found Wednesday, in a relatively rare ruling where...To view the full article, register now.
Already a subscriber? Click here to view full article